Live tape
Top 8, mentions 7d11,476SPCX2,435 mentions▲ +0.08GOOGL1,989 mentions▲ +0.02META1,794 mentions▲ +0.04TSLA1,707 mentions▲ +0.05NFLX973 mentions▲ +0.03QQQ888 mentions▲ +0.04AMZN848 mentions▲ +0.06NVDA842 mentions▲ +0.06

Equity · Healthcare

ANIX

NASDAQ

Anixa Biosciences (ANIX)

$2.99 +7.57% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 23, 2026
Price · Chart
63 sessions
$4.0 $2.5 28 Jul 23 Oct

The line runs $3.53 on 28 July through $2.99 on 23 October, on a scale from $2.5 to $4.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 63 sessions, 28 Jul – 23 Oct 2026
Market cap $103.8M
52-week range $2.38 – $6
Avg volume 10.5K

as of Oct 23, 2026

Anixa Biosciences (ANIX) insider trades

SEC Form 4 · last 90 days · newest reported trade 22 Oct 2026

In the 90 days to 26 Oct 2026, Anixa Biosciences insiders reported 8 open-market purchases and no sales (SEC Form 4).

Open-market buys 8
Open-market sells 0
Net bought $269K
Non-trade filings 0
Date Insider Type Shares Value
22 Oct 2026 KUMAR AMIT Chief Executive Officer Buy 8,000 $22K
30 Sep 2026 Catelani Michael President, COO, & CFO Buy 5,500 $16K
24 Sep 2026 KUMAR AMIT Chief Executive Officer Buy 7,000 $19K
24 Sep 2026 Baskies Arnold M Director Buy 5,000 $14K
23 Sep 2026 Titterton Lewis H jr Director Buy 49,036 $132K
10 Sep 2026 KUMAR AMIT Chief Executive Officer Buy 8,000 $22K
10 Sep 2026 Titterton Lewis H jr Director Buy 10,000 $27K
31 Jul 2026 KUMAR AMIT Chief Executive Officer Buy 5,000 $17K

Anixa Biosciences (ANIX) reported financials

SEC EDGAR XBRL SEC EDGAR

Anixa Biosciences reported net income of −$10.9M for the fiscal year ended 31 Oct 2025.

Figure Reported Period
Net income −$10.9M 31 Oct 2025 fiscal year
Diluted EPS −$0.34 31 Oct 2025 fiscal year
Total assets $15.1M 31 Jul 2026 at period end
Total equity $14.5M 31 Jul 2026 at period end

Anixa Biosciences (ANIX) earnings

SEC EDGAR

Anixa Biosciences last reported earnings on 31 Jul 2026 for Q3 2026, with EPS of −$0.08; no next date is announced in SEC filings yet.

Date Period EPS Revenue
31 Jul 2026 Q3 2026 −$0.08 —
30 Apr 2026 Q2 2026 −$0.07 —
31 Jan 2026 Q1 2026 −$0.08 —
31 Oct 2025 FY 2025 −$0.34 —
31 Jul 2025 Q3 2025 −$0.07 —
30 Apr 2025 Q2 2025 −$0.09 —
31 Jan 2025 Q1 2025 −$0.10 —
31 Oct 2024 FY 2024 −$0.39 $0M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Anixa Biosciences (ANIX) institutional holders (13F)

SEC Form 13F SEC EDGAR

3 of the 45 institutional funds we track reported a Anixa Biosciences position for the quarter ended 30 Jun 2026 — a combined $1.2M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Marshall Wace Added +89.6% shares 328,332 $919K
Renaissance Technologies Held (±25%) −2.9% shares 59,373 $166K
Citadel Advisors New position 31,887 $89K
Point72 Asset Management Exited
Two Sigma Investments Exited

Anixa Biosciences (ANIX) fails-to-deliver

SEC CNS data SEC

On 24 Sep 2026, 14 shares of Anixa Biosciences failed to deliver (about $39) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
24 Sep 2026 14 $39 <0.001%
23 Sep 2026 86 $240 <0.001%
15 Sep 2026 439 $1K 0.001%

Anixa Biosciences (ANIX): frequently asked questions

From live data

Have Anixa Biosciences insiders bought or sold shares recently?

In the 90 days to 26 Oct 2026, Anixa Biosciences insiders reported 8 open-market purchases and no sales (SEC Form 4).

How many institutions hold Anixa Biosciences?

3 of the 45 institutional funds we track reported a Anixa Biosciences position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Anixa Biosciences had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Anixa Biosciences is dated 24 Sep 2026, when 14 shares failed to deliver.

When did Anixa Biosciences last report earnings?

Anixa Biosciences last reported earnings on 31 Jul 2026 for Q3 2026, with EPS of −$0.08; no next date is announced in SEC filings yet.

What exchange is Anixa Biosciences listed on?

Anixa Biosciences trades on NASDAQ under the ticker ANIX.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 31 Jul 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings